Shaanxi Kanghui Pharmaceutical Co., Ltd.
SSE:603139.SS
26.2 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -111.997 | -50.775 | -76.785 | 32.997 | 36.458 | 46.069 | 57.765 | 63.183 | 65.234 | 62.205 | 62.742 | 55.822 | 40.398 |
| Depreciation & Amortization
| 59.891 | 38.727 | 25.343 | 16.372 | 11.956 | 11.904 | 10.751 | 9.904 | 9.325 | 9.081 | 8.649 | 6.751 | 2.673 |
| Deferred Income Tax
| 0 | 0 | -8.974 | -1.665 | -0.47 | -0.107 | -0.153 | 0.033 | -0.003 | -0.713 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -1.303 | -124.056 | 1.873 | -36.618 | 41.071 | 55.857 | 2.724 | -27.374 | -4.654 | -49.752 | -54.399 | -29.129 | 0 |
| Accounts Receivables
| 24.454 | -82.394 | -26.836 | 1.253 | 33.232 | 75.365 | 32.054 | -3.094 | -15.946 | -61.202 | -63.433 | 0 | 0 |
| Inventory
| -9.867 | 28.448 | -7.088 | -9.219 | -0.128 | -2.218 | -19.066 | -16.869 | -0.258 | 1.904 | -1.141 | 21.238 | 0 |
| Accounts Payables
| 0 | -65.294 | 44.771 | -26.987 | 8.437 | -17.183 | -10.111 | -7.444 | 11.553 | 10.259 | 0 | 0 | 0 |
| Other Working Capital
| -15.89 | -4.816 | -8.974 | -1.665 | -0.47 | -0.107 | 21.79 | -10.505 | -4.396 | -51.656 | -53.259 | -50.367 | 0 |
| Other Non Cash Items
| 90.704 | 63.97 | 100.002 | -5.332 | 4.239 | -6.304 | -8.605 | -2.115 | 1.813 | 6.969 | 5.733 | 5.908 | -40.398 |
| Operating Cash Flow
| 37.294 | -72.134 | 50.434 | 7.419 | 93.723 | 107.526 | 62.635 | 43.597 | 71.718 | 28.503 | 22.725 | 39.351 | 16.12 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -46.66 | -72.381 | -138.133 | -290.303 | -262.886 | -81.449 | -5.582 | -3.592 | -4.81 | -12.599 | -19.302 | -50.769 | -11.166 |
| Acquisitions Net
| -3.01 | 25.344 | 0.142 | -8.262 | -32.549 | 0.04 | -10.92 | -4.097 | 0.001 | 0.007 | 0.013 | 0.022 | 0 |
| Purchases Of Investments
| -30.012 | -78.706 | -307.28 | -476.903 | -348.12 | -602.453 | -1,059 | -400 | -30 | -145 | -4,628.1 | -923.5 | 0 |
| Sales Maturities Of Investments
| 56.653 | 78.154 | 399.372 | 396.711 | 447.457 | 618.526 | 1,023.633 | 151.987 | 60.109 | 145.457 | 4,628.617 | 894.915 | 0 |
| Other Investing Activites
| 6.506 | 1.625 | 2.5 | -0.223 | -1.759 | 2.1 | 4.168 | -4.979 | 0.495 | 0.09 | 7.012 | -12.684 | 1.29 |
| Investing Cash Flow
| -16.524 | -45.965 | -43.399 | -378.979 | -197.857 | -63.236 | -47.7 | -260.681 | 25.794 | -12.045 | -11.761 | -92.015 | -9.876 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -41.221 | 94.134 | 31.54 | 411.512 | 41.518 | 14.11 | -5.1 | -35 | -0.6 | -0.8 | -0.9 | -8.7 | 0.2 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.483 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -28.928 | -30.73 | -7.391 | -6.992 | -8.59 | -11.286 | -21.176 | -4.333 | -1.756 | -2.12 | -2.468 | -2.908 | -3.216 |
| Other Financing Activities
| 4.158 | -8.757 | 7.458 | 0.179 | -8.208 | -1.14 | -1.388 | 327.771 | -2.306 | -3.62 | -2.148 | 65.9 | -0.542 |
| Financing Cash Flow
| -65.991 | 54.646 | 7.591 | 378.307 | 23.333 | 1.227 | -27.664 | 288.438 | -2.906 | -4.42 | -3.048 | 54.292 | -3.558 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Net Change In Cash
| -45.22 | -63.453 | 14.626 | 6.746 | -80.801 | 45.517 | -12.729 | 71.354 | 94.607 | 12.039 | 7.916 | 1.628 | 2.686 |
| Cash At End Of Period
| 97.599 | 142.82 | 206.273 | 191.647 | 184.9 | 265.702 | 220.184 | 232.913 | 161.559 | 66.952 | 54.913 | 46.998 | 45.37 |